Invo Fertility, INC. (IVF) — 10-Q Filings

10-Q Filings (5)

• INVO Fertility's Losses Mount Amid Strategic Divestitures — Nov 17, 2025 Risk: high
  INVO Fertility, Inc. (IVF) reported a significant net loss of $25,333,069 for the nine months ended September 30, 2025, a substantial increase from the $5,472,3
• INVO Fertility's Net Loss Widens to $22.7M Amid NTI Divestiture — Aug 14, 2025 Risk: high
  INVO Fertility, Inc. (IVF) reported a significant net loss of $22.69 million for the six months ended June 30, 2025, a substantial increase from the $3.84 milli
• INVO Fertility, Inc. Files Q1 2025 10-Q — May 20, 2025 Risk: low
  INVO Fertility, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as NAYA Biosciences, Inc. and INVO Bioscience, Inc., is in
• INVO Bioscience Q2 2024 10-Q Filed — Aug 14, 2024 Risk: medium
  INVO Bioscience, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported clinic revenue for Q2 2024 and the first six months of 2024, with
• INVO Bioscience, Inc. Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: low
  INVO Bioscience, Inc. (IVF) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. INVO Bioscience, Inc. filed a 10-Q report for the period ending March

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX